Ignite Creation Date:
2025-12-25 @ 1:02 AM
Ignite Modification Date:
2026-01-04 @ 4:40 AM
Study NCT ID:
NCT05904093
Status:
RECRUITING
Last Update Posted:
2025-09-15
First Post:
2023-06-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study to Evaluate the Safety and Tolerability of Escalating Doses of Fostamatinib in Subjects With Stable Sickle Cell Disease
Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-12-18
Start Date Type:
ACTUAL
Primary Completion Date:
2026-05-14
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-05-14
Completion Date Type:
ESTIMATED
First Submit Date:
2023-06-13
First Submit QC Date:
None
Study First Post Date:
2023-06-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-12
Last Update Post Date:
2025-09-15
Last Update Post Date Type:
ESTIMATED